Location History:
- Novi, MI (US) (2019)
- Detroit, MI (US) (2014 - 2022)
- Highland, MD (US) (2020 - 2024)
Company Filing History:
7 out of 580 
4 out of 3,539 
1 out of 3,688 
Years Active: 2014-2024
Title: The Innovative Work of Inventor Sujatha Kannan in Ocular Drug Delivery
Introduction:
Inventor Sujatha Kannan, based in Detroit, MI, is a prolific innovator with a remarkable contribution to the field of ocular drug delivery. With a total of 7 patents to her name, Kannan has made significant strides in developing novel compositions and methods for the treatment of ocular diseases.
Latest Patents:
Kannan's latest patents focus on utilizing dendrimers for sustained release of compounds in the treatment of ocular diseases such as macular degeneration, diabetic retinopathy, and retinitis pigmentosa. Her inventions include dendrimer-based compositions for targeted delivery to cells and tissues. Additionally, she has developed injectable dendrimer hydrogel nanoparticles for efficient drug delivery and imaging applications.
Career Highlights:
Having worked with prestigious institutions such as Wayne State University and The United States of America, as Represented by the Secretary, Department of Health and Human Services, Kannan has established herself as a leading expert in the field. Her research and innovations have paved the way for advancements in ocular drug delivery systems.
Collaborations:
Throughout her career, Sujatha Kannan has collaborated with esteemed colleagues such as Kannan Rangaramanujam and Roberto Romero. These collaborations have led to groundbreaking discoveries and furthered the development of advanced drug delivery technologies in the field of ophthalmology.
Conclusion:
In conclusion, Sujatha Kannan's dedication to innovation and her pioneering work in ocular drug delivery have significantly impacted the medical field. Her patents serve as a testament to her commitment to improving treatment options for patients with ocular diseases. Kannan's contributions continue to inspire future advancements in the field, setting a high standard for innovative research and development in healthcare.